Jennifer Michaelson's most recent trade in Cullinan Oncology Inc was a trade of 3,756 Common Stock done at an average price of $8.5 . Disclosure was reported to the exchange on Feb. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 3,756 | 142,004 | - | 8.5 | 32,039 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 50,000 | 145,760 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 06 Jan 2025 | 4,000 | 95,760 | - | 12.5 | 50,040 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 4,693 | 99,760 | - | 11.4 | 53,547 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.52 per share. | 12 Dec 2024 | 3,489 | 104,453 | - | 12.5 | 43,682 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.64 per share. | 05 Nov 2024 | 8,000 | 107,942 | - | 15.6 | 125,120 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 05 Sep 2024 | 8,000 | 115,942 | - | 18.1 | 144,720 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.33 per share. | 05 Jul 2024 | 8,000 | 123,942 | - | 16.3 | 130,640 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 9.00 per share. | 01 Jul 2024 | 2,360 | 131,942 | - | 9 | 21,240 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 May 2024 | 50,000 | 187,582 | - | 4.3 | 215,000 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 50,000 | 138,593 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 06 May 2024 | 37,723 | 149,859 | - | 27.8 | 1,049,454 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.54 per share. | 06 May 2024 | 20,277 | 129,582 | - | 28.5 | 578,706 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 5,606 | 132,987 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 06 May 2024 | 5,606 | 129,582 | - | 30.1 | 168,516 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 May 2024 | 5,606 | 135,188 | - | 4.3 | 24,106 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 50,000 | 137,582 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,145 | 87,582 | - | 8.5 | 9,733 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 238 | 88,727 | - | 8.2 | 1,956 | Common Stock |
| Cullinan Oncology Inc | Michaelson Jennifer | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 12 Dec 2023 | 1,068 | 88,965 | - | 7.8 | 8,341 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 238 | 90,033 | - | 12.9 | 3,080 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 Jun 2023 | 11,900 | 102,347 | - | 4.3 | 51,170 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 11,900 | 188,693 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 06 Jun 2023 | 11,900 | 90,447 | - | 12.3 | 146,489 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 100 | 188,593 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 06 Jun 2023 | 100 | 90,447 | - | 12.4 | 1,240 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 06 Jun 2023 | 100 | 90,547 | - | 4.3 | 430 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 239 | 90,447 | - | 8.8 | 2,094 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 8.78 per share. | 12 May 2023 | 193 | 90,686 | - | 8.8 | 1,695 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 238 | 90,879 | - | 10.7 | 2,549 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 10.22 per share. | 12 Apr 2023 | 176 | 91,117 | - | 10.2 | 1,799 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 238 | 91,293 | - | 11.3 | 2,694 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 38,500 | 91,531 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 13.30 per share. | 25 Nov 2022 | 4,000 | 53,031 | - | 13.3 | 53,200 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 25 Nov 2022 | 4,000 | 57,031 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2022 | 4,000 | 200,593 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 12.40 per share. | 27 Sep 2022 | 4,000 | 53,031 | - | 12.4 | 49,600 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 27 Sep 2022 | 4,000 | 57,031 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2022 | 4,000 | 204,593 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 08 Aug 2022 | 1,385 | 53,031 | - | 15.0 | 20,789 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 1,385 | 208,593 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 08 Aug 2022 | 1,385 | 54,416 | - | 4.3 | 5,956 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 25 Jul 2022 | 8,000 | 61,031 | - | 4.3 | 34,400 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 8,000 | 209,978 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 14.51 per share. | 25 Jul 2022 | 8,000 | 53,031 | - | 14.5 | 116,080 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 10.90 per share. | 30 Jun 2022 | 1,620 | 53,031 | - | 10.9 | 17,658 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 57,000 | 57,000 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 28,500 | 51,411 | - | 0 | Common Stock | |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 18 Oct 2021 | 4,000 | 26,911 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2021 | 4,000 | 217,978 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 21.10 per share. | 18 Oct 2021 | 3,396 | 23,515 | - | 21.1 | 71,656 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 23.61 per share. | 18 Oct 2021 | 400 | 22,911 | - | 23.6 | 9,444 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 22.40 per share. | 18 Oct 2021 | 204 | 23,311 | - | 22.4 | 4,570 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 20 Sep 2021 | 4,000 | 26,911 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Sep 2021 | 4,000 | 221,978 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 24.34 per share. | 20 Sep 2021 | 3,200 | 23,711 | - | 24.3 | 77,888 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 25.20 per share. | 20 Sep 2021 | 800 | 22,911 | - | 25.2 | 20,160 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. | 18 Aug 2021 | 4,000 | 26,911 | - | 4.3 | 17,200 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2021 | 4,000 | 225,978 | - | - | Stock Option (Right to Buy) | |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 18 Aug 2021 | 2,863 | 24,048 | - | 27.5 | 78,733 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 18 Aug 2021 | 1,137 | 22,911 | - | 28.1 | 31,916 | Common Stock |
| Cullinan Oncology Inc | Jennifer Michaelson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 79,999 | 79,999 | - | - | Stock Option (Right to Buy) |